Getinge (OTCMKTS:GNGBY) Downgraded to Hold Rating by Zacks Research

Zacks Research cut shares of Getinge (OTCMKTS:GNGBY) from a strong-buy rating to a hold rating in a report released on Thursday,Zacks reports.

Several other equities analysts have also issued reports on the stock. UBS Group initiated coverage on shares of Getinge in a report on Wednesday, September 2nd. They set a “hold” rating for the company. Nordea Equity Research lowered Getinge from a “buy” rating to a “hold” rating in a research report on Monday, August 31st. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has an average rating of “Hold”.

Getinge Stock Down 1.3%

OTCMKTS:GNGBY opened at $23.93 on Thursday. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.31 and a quick ratio of 0.74. The firm’s 50-day moving average price is $24.58 and its 200-day moving average price is $21.93. The company has a market capitalization of $6.52 billion, a PE ratio of 22.79 and a beta of 0.93. Getinge has a 1-year low of $18.99 and a 1-year high of $25.98.

Getinge (OTCMKTS:GNGBY) last posted its quarterly earnings data on Friday, July 17th. The company reported $0.38 EPS for the quarter. The business had revenue of $894.87 million for the quarter. Getinge had a net margin of 7.81% and a return on equity of 11.12%. On average, equities analysts predict that Getinge will post 1.38 EPS for the current fiscal year.

Getinge Company Profile

Getinge AB is a Sweden-based medical technology company that develops products and solutions for hospitals, healthcare providers and life science organizations. Founded in 1904 in Getinge, Sweden, the company serves customers through operations and sales channels across Europe, North America, Asia-Pacific and other international markets.

Getinge organizes its business around Acute Care Therapies, Life Science and Surgical Workflows. Its offerings include ventilators, anesthesia systems, patient monitoring and cardiovascular support technologies, as well as equipment used in intensive care and other acute-care settings.